You are here: Industry Insights > transparency

News List

FDA seeks public feedback on new drug approval transparency efforts worldpharmanews
June 27, 2019
The U.S. Food and Drug Administration issued a Federal Register notice, New Drugs Regulatory Program Modernization: Improving Approval Package Documentation ...
Prescription drug costs steadily soar, yet price transparency is lacking worldpharmanews
June 06, 2019
After reviewing tens of millions of insurance claims for the country’s 49 most popular brand-name prescription drugs, a team from Scripps Research Translational Institute found ...
WHO announces support for drug pricing transparency drugs
June 03, 2019
Member countries of WHO have agreed to support pricing transparency for medicines, vaccines and other health products.
WHO adopts resolution on drug pricing transparency pharmaceutical-technology
May 31, 2019
Member countries of the World Health Organization (WHO) have agreed to support pricing transparency for medicines, vaccines and other health products.
At WHO Forum on Medicines, countries and civil society push for greater transparency and fairer prices biospectrumasia
April 16, 2019
Recently, the forum on medicines co-hosted by the World Health Organization (WHO) and the Government of South ……
Report finds NICE unaware of financial interests of patient groups pharmaceutical-technology
January 21, 2019
A report by the London School of Tropical Medicine (LSTM) found that patient organisations consulted by the UK’s National institute of Health and Care Excellence (NICE) to advise on appraisals of medicines and treatments....
Expect more transparency around pharma's advocacy group partnerships in 2019 fiercepharma
December 24, 2018
Advocacy groups and pharma companies often work hand in hand, especially in rare diseases. This year, however, saw some of the shine wear off of those close relationships as politicians and the media raised red flags over payments from pharma companies.
Expect more transparency around pharma's advocacy group partnerships in 2019 fiercepharma
December 20, 2018
Advocacy groups and pharma companies often work hand in hand, especially in rare diseases. This year, however, saw some of the shine wear off of those close relationships as politicians and the media raised red flags over payments from pharma companies.
Expect more transparency around pharma's advocacy group partnerships in 2019 fiercepharma
December 20, 2018
Advocacy groups and pharma companies often work hand in hand, especially in rare diseases.
IMA condemns the West Bengal Clinical Establishment ACT financialexpress
April 27, 2017
Urges three lakh members to observe a National Black Day on April 27, 2017